Anthony Johnson
Empire Genomics LLC, USA
Biography
Anthony Johnson is the President and CEO of Empire Genomics, a leading molecular diagnostic firm specializing in the delivery of precision medicine in the oncology arena. Since the firm’s founding, he has raised multiple rounds of funds, signed multimillion dollar licensing and distribution deals and has developed many companion diagnostic assays that are in clinical development as therapeutic selection markers. He is also a Founding Partner of Buffalo Biosciences, a life science strategic management services firm, where he consults on areas of healthcare. Previously, he has worked for Invitrogen Corporation, where he created and led the firm’s stem cell and regenerative medicine franchise. He has earned his MBA from the Alliance Manchester Business School in Manchester, England and a Bachelor's degree in Biology from Fisk University in Nashville, Tennessee. He is a Fellow of the second class of the Health Innovators Fellowship and a Member of the Aspen Global Leadership Network.
Abstract
Abstract : Developing a companion Dx in oncology: From academic research project to companion trial
